These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7125971)

  • 1. How to comply with the Food and Drug Administration Administration's "Investigational Device Exemption" regulations including an application form (revised January 1982). Prepared by the ISAIO Standards Committee. Part 2.
    Morton WA; Dobelle WH; Lysaght MJ; Serkes K; Siemsen A; Villaroel F
    Artif Organs; 1982 May; 6(2):235-48. PubMed ID: 7125971
    [No Abstract]   [Full Text] [Related]  

  • 2. How to comply with the Food and Drug Administration's "Investigational Device Exemption (IDE)" regulations including an application form (revised January 1982).
    Artif Organs; 1982 Feb; 6(1):91-118. PubMed ID: 7073530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing the adverse effects of the medical device amendments of 1976 on innovation in artificial organs research. (Including a proposed short-form application to the FDA for investigational exemptions).
    Dobelle WH
    Artif Organs; 1977 Aug; 1(1):65-75. PubMed ID: 356815
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of regulations on artificial organs research.
    Morton WA; DeVries WC; Dobelle WH; Serkes KD; Sheridan R; Dennis C
    Trans Am Soc Artif Intern Organs; 1983; 29():770-3. PubMed ID: 6673323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the Investigational Device Exemption Regulation.
    Gatling RR
    Diabetes Care; 1982; 5(3):282-3. PubMed ID: 6756837
    [No Abstract]   [Full Text] [Related]  

  • 7. New standards for clinical research.
    Hecht A
    FDA Consum; 1978 Nov; 12(9):16-9. PubMed ID: 10308752
    [No Abstract]   [Full Text] [Related]  

  • 8. Ensuring Justice in Access to Investigational Neurological Drugs.
    Kearns L; Bateman-House A; Caplan A
    Semin Neurol; 2018 Oct; 38(5):583-588. PubMed ID: 30321898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration's "Exception from informed consent requirements for emergency research": a special report from the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine.
    Halperin H; Paradis N; Mosesso V; Nichol G; Sayre M; Ornato JP; Gerardi M; Nadkarni VM; Berg R; Becker L; Siegler M; Collins M; Cairns CB; Biros MH; Vanden Hoek T; Peberdy MA; ;
    Circulation; 2007 Oct; 116(16):1855-63. PubMed ID: 17893277
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application.
    Novack G
    Retina; 2005 Dec; 25(8 Suppl):S96-S97. PubMed ID: 16374362
    [No Abstract]   [Full Text] [Related]  

  • 14. Digitizing Consent: The Food and Drug Administration’s Draft Guidance on Electronic Informed Consent.
    Simon CM; Klein DW; Schartz HA
    IRB; 2016; 38(5):15-8. PubMed ID: 30146859
    [No Abstract]   [Full Text] [Related]  

  • 15. THE FOOD AND DRUG ADMINISTRATION'S VIEW OF INVESTIGATIONAL DRUGS.
    MEYERS EL
    Am J Pharm Sci Support Public Health; 1963 Jun; 135():219-29. PubMed ID: 14046043
    [No Abstract]   [Full Text] [Related]  

  • 16. The Food and Drug Administration's experimental drug approval system: is it good for your health?
    Myers BE
    Houst Law Rev; 1991 Jan; 28(1):309-36. PubMed ID: 12426696
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical devices: procedures for investigational device exemptions.
    Fed Regist; 1978 May; 43(93):20725-57. PubMed ID: 10307350
    [No Abstract]   [Full Text] [Related]  

  • 18. Device reliability.
    Mussivand T; Keon WJ; Hoeppner DW; Ciarkowski AA; Kung RT; Freeland WJ; Butler KC
    ASAIO J; 1994; 40(1):97-9. PubMed ID: 8186504
    [No Abstract]   [Full Text] [Related]  

  • 19. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA, off-label use, and informed consent: debunking myths and misconceptions.
    Beck JM; Azari ED
    Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.